glp 1 agonist new drug GLP-1 Drugs from the Gray Market Study finds GLP-1 receptor agonists

Commonly Reported Side Effects Mild nausea or lightheadedness (typically early in the cycle) Redness or irritation at injection site Temporary headache or fatigue Tingling or nerve sensitivity in the treated area (rare) These effects are usually transient and dose-dependent

Neuropeptides control the dynamic behavior of airway mucosal dendritic cells

1 Introduction Autoimmune diseases (AIDs) are a group of chronic inflammatory disorders caused by the breakdown of immune tolerance, including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), inflammatory bowel disease (IBD), multiple sclerosis (MS), type 1 diabetes mellitus (T1DM), and psoriasis

Bianca Itariu: declares no conflict of interest relevant to this study